In our previous manuscript, we have developed a specific LSD1 inhibitor named ZY0511, which inhibits LSD1 at nanomolar concentration30, exhibits growth inhibition against human colorectal and cervical cancer xenografts in nude mice, and enhances the sensitivity of human colorectal cancer cells to 5-fluorouracil31,32. Here, KDM1A is linked to cervical carcinoma.